Status:
COMPLETED
Transcranial Magnetic Stimulation Treatment of Hoarding Disorder
Lead Sponsor:
Hartford Hospital
Collaborating Sponsors:
Neuronetics
Conditions:
Hoarding
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is multiple baseline study including up to three participants with a primary diagnosis of hoarding disorder. All patients will receive unblinded repetitive transcranial magnetic stimulation study...
Detailed Description
Study assessments will be conducted at pre-baseline, weekly during baseline assessment (until a stable baseline is established, but not less than 2, 4, and 6 weeks for patients respectively), weekly d...
Eligibility Criteria
Inclusion
- Diagnosed with hoarding disorder as primary disorder
- Clinical Global Impression Score \> 3
- Saving Inventory-Revised score \> 39
Exclusion
- Any contraindication for participation in magnetic resonance imaging or transcranial magnetic stimulation
- Severe and/or unstable medical or psychiatric condition that require immediate medical attention
- Diagnosed with current major depressive episode
- Currently taking psychiatric medication
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT02236767
Start Date
July 1 2014
End Date
December 1 2014
Last Update
October 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06106